Epilepsy care has evolved dramatically in recent years. Advances in diagnostics, surgical techniques, and neuromodulation are transforming how physicians treat patients with drug-resistant epilepsy.

In this episode of Doc to Doc, neurosurgeon and chief medical executive of Miami Neuroscience Institute Dr. Michael McDermott is joined by epilepsy experts, Dr. Aviva Abosch, deputy director of the Institute as well as director of epilepsy surgery and co-director of functional neurosurgery and Dr. Luis Tornes, neurologist and the director of the epilepsy program at the Miami Neuroscience Institute at Baptist Health South Florida.

Together they explore how multidisciplinary teams diagnose epilepsy, evaluate patients for surgery, and use advanced technologies such as responsive neurostimulation, deep brain stimulation, and stereotactic EEG to improve outcomes.

Topics include:
· How physicians specialize in epilepsy care
· The role of epilepsy monitoring units
· Surgical approaches for drug-resistant epilepsy
· Neuromodulation technologies like RNS, DBS, and VNS
· Emerging therapies including biologics and cellular treatments

This conversation offers a deeper look at how neuroscience innovation is improving quality of life for patients living with epilepsy.

Learn more about the Epilepsy Program at Miami Neuroscience Institute:

baptisthealth.net/neuroscience

Host:

Michael McDermott, M.D.
Neurosurgeon & Chief Medical Executive
Baptist Health Miami Neuroscience Institute
Chair, Neurosciences, FIU

Guests:

Aviva Abosch, M.D.
Neurosurgeon & Deputy Director
Baptist Health Miami Neuroscience Institute

Luis Tornes, M.D.
Neurologist & Director of the Epilepsy Program
Baptist Health Miami Neuroscience Institute

If you found this episode helpful, you may also enjoy:

The Pituitary Playbook - Functional Tumors, Vision Risks & Endoscopic Solutions

Evolving Advances in Brain Tumor Care

TMS: Making Waves with Treatment Resistant Depression

In this episode of Baptist Health Doc to Doc, Dr. John Diaz and Dr. Mehran Habibi discuss how artificial intelligence, robotic surgery, precision medicine, and targeted therapies are transforming breast cancer and gynecologic oncology in 2026.

Topics include:

- AI-assisted breast imaging and surgical planning
- Robotic hysterectomy and minimally invasive cancer surgery
- De-escalation of sentinel lymph node biopsy
- Circulating tumor DNA (MRD) and treatment personalization
- Antibody-drug conjugates (ADCs)
- Oral SERDs and evolving endocrine therapy
- HPV vaccination and cervical cancer prevention


As cancer care moves from radical procedures to optimized, personalized treatment, innovation is improving outcomes while reducing recovery time and surgical risk.

Presenters:

John P. Diaz, M.D., FACOG, FACS
Chief of Gynecologic Oncology
Baptist Health Miami Cancer Institute

Mehran Habibi, M.D., MBA
Deputy Chief of Breast Surgery
Baptist Health Cancer Care

Join Joseph Panoff, M.D., radiation oncologist at Baptist Health Miami Cancer Institute, and Youssef Zeidan, M.D., radiation oncologist at Lynn Cancer Institute, for an in-depth physician-to-physician discussion on modern breast cancer radiation therapy.

They explore how photon-based radiation has evolved over the last two decades—from early planning techniques to today’s highly conformal approaches that improve precision while reducing toxicity. The conversation also examines emerging comparisons between proton and photon therapy, including how each modality impacts cardiac exposure, skin toxicity, and long-term survivorship considerations.

This episode highlights the importance of individualized treatment planning, the growing focus on safely reducing unnecessary treatment, and how collaboration across leading cancer institutes is shaping the future of radiation oncology.

Host:
Joseph Panoff, M.D.
Radiation Oncologist
Baptist Health Miami Cancer Institute

Guest:
Youssef Zeidan, M.D.
Radiation Oncologist
Lynn Cancer Institute